13F Holdings
中文EN

PMI Picard Medical, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 2030617 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.6%
TTM net income YoY37.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin26.2%
Operating margin-267.2%
Net margin-371.2%
FCF margin—
EBITDA margin-264.0%

Returns

ROE-425.6%
ROA-175.2%
ROIC (approx.)-350.7%
Asset turnover0.47x

Leverage & solvency

Liabilities / assets85.3%
Debt / equity0.00x
Current ratio0.99x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.58x
Accruals ratio-73.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$4.94M$4.39M
Cost of revenue$5.14M$4.50M
Gross profit-$204,000-$112,000
R&D expense$3.05M$3.38M
SG&A expense$10.00M$10.22M
Operating income-$13.26M-$13.71M
Pretax income-$26.97M-$21.07M
Income tax$35,000-$15,000
Net income-$27.00M-$21.05M
EBITDA-$13.09M-$13.49M
EPS (basic)-0.75-2.99
EPS (diluted)——
Balance sheet
Cash & equivalents$7.45M$96,000
Receivables—$513,000
Inventory$7.30M$8.12M
Current assets$20.73M$9.79M
PP&E, net$183,000$227,000
Goodwill$615,000$615,000
Intangibles$509,000$596,000
Total assets$22.55M$12.11M
Current liabilities$18.70M$35.33M
Total liabilities$18.76M$35.84M
Shareholders' equity$3.79M-$44.00M
Shares outstanding1.47M7.94M
Cash flow statement
Operating cash flow-$15.67M-$11.87M
Investing cash flow—$0
Financing cash flow$27.08M$11.74M
Depreciation & amortization$163,000$226,000
Stock-based compensation$754,000$886,000

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.